Clinical evaluation of Lugol's iodine staining in the treatment of stage I-II squamous cell carcinoma of the tongue

International Journal of Oral and Maxillofacial Surgery

Volumn 40, Issue 6, 2011, Pages 593-596

  Umeda, M ^a   Shigeta, T ^a   Takahashi, H ^a   Minamikawa, T ^a   Komatsubara, H ^a   Oguni, A ^a   Shibuya, Y ^a   Komori, T ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Lugol's iodine; Oral squamous cell carcinoma; OSCC; Staining; Tongue

Indexed keywords

LUGOL;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; DISEASE SEVERITY; DISTANT METASTASIS; EPITHELIUM DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NECK METASTASIS; OUTCOME ASSESSMENT; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COLORING AGENTS; DISEASE-FREE SURVIVAL; EPITHELIUM; FEMALE; FOLLOW-UP STUDIES; GLOSSECTOMY; HUMANS; IODIDES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PRECANCEROUS CONDITIONS; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TONGUE NEOPLASMS;

EID: 79956260090     PISSN: 09015027     EISSN: 13990020     Source Type: Journal    
DOI: 10.1016/j.ijom.2010.11.026     Document Type: Article

References (22)

1. AKASAKA Y, OKUDA J, IDA K, TORIIE S, NISHINO H, KIMOTO K. Vital staining of esophageal mucosa using endoscopic spraying technique of Lugol's solution - for the aid of esophagoscopic diagnosis of the cancer. Gastroenterol Endosc 1976: 18: 84-92.
2. AL-RAJHI N, KHAFAGA Y, EL-HUSSEINY J, SALEEM M, MOURAD W, AL-OTIESCHAN A, AL-AMRO A. Early stage carcinoma of oral tongue: prognostic factors for local control and survival. Oral Oncol 2000: 36: 508-514.
3. BAEK CH, SON YI, JEONG HS, CHUNG MK, PARK KN, KO YH, KIM HJ. Intraoral sonography-assisted resection of T1-2 tongue cancer for adequate deep resection. Otolaryngol Head Neck Surg 2008: 139: 805-810.
4. EPSTAIN JB, SCULLY C, SPINELLI JJ. Toluidine blue and Lugol's iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. J Oral Pathol Med 1992: 21: 160-163.
5. KESKI-SÄNTTI H, ATULA T, TIKKA J, HOLLMÉN J, MÄKITIE AA, LEIVO I. Predictive value of histopathologic parameters in early squamous cell carcinoma of oral tongue. Oral Oncol 2007: 43: 1007-1013.
6. KOUZU T, TAKAHASHI H, ONOZAWA K, KUGA K, MIYAJIMA T, HUKAO K, AKAI H, MARUYAMA T, HAMANO Y, IINO M, HORIE H, ISHIKAWA T, SATO H, ISANO K, SATO H. Experiences on endoscopical esophageal staining. Prog Digest Endosc 1975: 6: 41-44.
7. KURITA H, KURASHINA K. Vital staining with iodine solution in delineating the border of oral dysplastic lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996: 81: 275-280.
8. MÄKITIE AA, KOIVUNEN P, KESKI-SÄNTTI H, TÖRNWALL J, PUKKILA M, LARANNE J, LUUKKAA M, VUOLA J, JOENSUU T, KAJANTI M, GRÉNMAN R. Oral tongue carcinoma and its treatment in Finland. Eur Arch Otorhinolaryngol 2007: 264: 263-267.
9. MCMAHON J, DEVINE JC, MCCAUL JA, MCLELLAN DR, FARROW A. Use of Lugol's iodine in the resection of oral and oropharyngeal squamous cell carcinoma. Br J Oral Maxillofac Surg 2010: 48: 84-87.
10. MERKX MA, VAN GULICK JJ, MARRES HA, KAANDERS JH, BRUASET I, VERBEEK A, DE WILDE PC. Effectiveness of routine follow-up of patients treated for T1-2N0 oral squamous cell carcinomas of the floor of mouth and tongue. Head Neck 2006: 28: 1-7.
11. MIYAZAKI S, KAWAHARA K, WATANABE S, HIRATA M, IIDA Y, OKITA K, OKAZAKI Y, TAKENOTO T. Fundamental studies on Lugol staining method of esophageal carcinomas. Gastroenterol Endosc 1981: 23: 503-513.
12. NAKANISHI Y, OCHIAI A, YOSHIMURA K, KATO H, SHIMODA T, YAMAGUCHI H, TACHIMORI Y, WATANABE H, HIROHASHI S. The clinicopathologic significance of small areas unstained by Lugol's iodine in the mucosa surrounding resected esophageal carcinoma. An analysis of 147 cases. Cancer 1998: 82: 1454-1459.
13. PO WING YUEN A, LAM KY, LAM LK, HO CM, WONG A, CHOW TL, YUEN WF, WEI WI. Prognostic factors of clinically stage I and II oral tongue carcinoma-a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck 2002: 24: 513-520.
14. SAWADAISHI K, KARAKI Y, KAWAGUCHI M, SAITOH M, SAEKI T, YAMADA A, SHIMAZAKI K, MUNAKATA S, SAKAMOTO T, SHINBO T, TAZAWA K, FUJIMAKI M. The examination of the coloring mechanism of the human esophageal epithelium by Lugol's solution. J Jpn Bronchoesophagol Soc 1989: 40: 252-257.
15. SCHILLER W. Early diagnosis of carcinoma of the cervix. Surg Gynecol Obstet 1933: 56: 210-222.
16. SUGIMACHI K, KITAMURA K, BABA K, IKEBE M, KUWANO H. Endoscopic diagnosis of early carcinoma of the esophagus using Lugol's solution. Gastrointest Endosc 1992: 38: 657-661.
17. ULANOVSKI D, STERN Y, ROIZMAN P, DRUZD T, SHPITZER T, GUTMAN D, FEINMESSER R. Value of minimal residual disease in patients with early cancer of the tongue. Am J Otolaryngol 2004: 25: 240-244.
18. UMEDA M, NISHIMATSU N, SHIBUYA Y, YOKOO S, FUJIOKA M, KOMORI T. Late local recurrence of squamous cell carcinoma of the oral cavity. Asian J Oral Maxillofac Surg 1999: 11: 131-136.
19. UMEDA M, KOMATSUBARA H, NISHIMATSU N, YOKOO S, SHIBUYA Y, KOMORI T. High dose rate (HDR) interstitial brachytherapy for stage I-II tongue cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000: 90: 667-670.
20. UMEDA M, KOMATSUBARA H, OJIMA Y, MINAMIKAWA T, SHIBUYA Y, YOKOO S, KOMORI T. A comparison of brachytherapy and surgery for the treatment of stage I-II squamous cell carcinoma of the tongue. Int J Oral Maxillofac Surg 2005: 34: 739-744.
21. YAJIMA Y, NOMA H, FURUYA Y, NOMURA T, YAMAUCHI T, KASAHARA K, HATADA K, TAKANO M. Quantification of telomerase activity of regions unstained with iodine solution that surround oral squamous cell carcinoma. Oral Oncol 2004: 40: 314-320.
22. YOKOO K, NOMA H, INOUE T, HASHIMOTO S, SHIMONO M. Cell proliferation and tumour suppressor gene expression in iodine unstained area surrounding oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2004: 33: 75-83.